Lv51
1005 积分 2020-07-19 加入
TL1A: A New Potential Target in the Treatment of Inflammatory Bowel Disease
2小时前
已完结
Abstract 5541: BGB-15025, a potent and selective HPK1 inhibitor, is efficacious as a single agent or in combination with PD-1 antibody in multiple tumor models
5个月前
已完结
GRC 54276, a novel small molecule inhibitor of HPK1 has entered phase 1/2 clinical trial insolid malignancies and Hodgkin's/non Hodgkin's lymphoma
5个月前
已关闭
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial
6个月前
已完结
Analysis of lorlatinib analogs reveals a roadmap for targeting diverse compound resistance mutations in ALK-positive lung cancer
8个月前
已完结
Targeting drug-resistant mutations in ALK
8个月前
已完结
Discovery of Flexible Naphthyltriazolylmethane-based Thioacetic Acids as Highly Active Uric Acid Transporter 1 (URAT1) Inhibitors for the Treatment of Hyperuricemia of Gout
1年前
已完结
Development of an Acrylate Derivative Targeting the NLRP3 Inflammasome for the Treatment of Inflammatory Bowel Disease
1年前
已完结
Gout therapeutics: new drugs for an old disease
1年前
已完结
皖公网安备34019202002308
